Reticulon 3 (RTN3) is an endoplasmic reticulum protein that has previously been shown to play a role in neurodegenerative diseases, but little is known about its role in lipid metabolism.
O
besity and its comorbidities such as heart disease, diabetes mellitus, and certain types of cancers contribute to mostly preventable deaths in both adults and children. The increasing rates of these health issues are the most serious and arduous public health challenge of the 21st century. 1 Although many possible contributors and mediators involved in the development and maintenance of obesity have been reported in recent years, [2] [3] [4] mechanistic links to these factors remained to be fully established. Among these factors, triglycerides and triglyceride metabolism are linked to the occurrence of obesity and many obesityrelated diseases. Triglyceride is neutral fat that is stored mostly in lipid droplets (LDs), which are defined as the major fat storage organelles in eukaryotes. 5, 6 Human adipocytes are the most highly specialized cell type and can store vast quantity of energy in LDs, primarily as triglycerides. To accommodate more triglycerides, adipocytes frequently form new LDs and expand existing ones, increasing the triglyceride storage and LD capacity in the adipose tissue, which is the major mechanism of obesity in adults. [7] [8] [9] The reticulon (RTN) protein family consists of RTN1 to RTN4 in mammalian systems and has a signature C-terminal RTN homolog domain. 10, 11 Biochemically, RTNs have been shown to shape tubular endoplasmic reticulum (ER) structure as a result of the presence of a ω-(wedge-shaped) membrane topology in which both the N-and C-terminal domains face the cytosolic side. 12, 13 Functionally, RTNs have been found to regulate neurite outgrowth, 14 to negatively modulate the activity of Alzheimer β-secretase, 15, 16 and to pathologically link to axonopathy in hereditary spastic paraplegias. 17 The functions of RTNs in human peripheral organs remain underexplored. For example, it has not been established whether RTN3 expression has any effects on obesity or triglyceride metabolism.
To this end, we noted an obesity phenotype and abnormal accumulation of triglycerides in the plasma and fat tissue of transgenic mice overexpressing the wild-type (WT) human RTN3 gene (Tg-RTN3). We then collected fat tissue from obese individuals and normalweight, age-matched control subjects, as well as plasma samples of patients with hypertriglyceridemia and control subjects. Strikingly, high expression of human RTN3 is associated with obesity and high levels of triglycerides in fat tissue and plasma. To further establish whether RTN3 contributes to elevated triglyceride concentration in plasma and fat tissue, we examined RTN3-null mice. We showed that RTN3-null mice that were fed a high-fat diet (HFD) displayed a triglyceride accumulation barrier. In addition, overexpressing the RTN homologous gene (ret-1) in Caenorhabditis elegans increased the number and size of large LDs. Conversely, knocking down the expression of ret-1 reduced the number and size of large LDs in C elegans lacking daf-22, which further indicates a role of RTN3 in triglyceride accumulation. Our mechanistic study revealed that RTN3 interacts with heat shock protein family A (Hsp70) member 5 (HSPA5) and regulates the activation of sterol regulatory element-binding protein (SREBP) 1c and AMP-activated kinase (AMPK), which are 2 important downstream molecules in triglyceride biosynthesis. Thus, our findings suggest that RTN3 may contribute to obesity and hypertriglyceridemia, possibly by modifying triglyceride synthesis and LD size expansion. Furthermore, elevated RTN3 in plasma may indicate an increased risk of obesity.
METHODS
The data, analytical methods, and study materials will not be made available to other researchers for the purposes of reproducing the results or replicating the procedure.
Mouse Strains, Cell Lines, Human Tissues Samples, and Reagents
Tg-RTN3 mice and RTN3-null mice were generated, and genotyping was performed as described previously. 16, 18, 19 3T3L1 preadipocytes were purchased from the Cell Bank of Shanghai Institutes for Biological Sciences (Shanghai, China) and maintained at 37°C in a humidified, 5% CO 2 -controlled atmosphere in DMEM supplemented with 10% fetal bovine serum, 50 IU/mL penicillin, 50 mmol/L streptomycin, and glutamine.
The study protocol was approved by the Review Board of the Central South University in China. All human subjects
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What Is New?
• We established a linkage between reticulon 3 (RTN3) and obesity with hypertriglyceridemia in humans and animals, and transgenic mice overexpressing the wild-type human RTN3 gene could be a suitable model for obesity and hypertriglyceridemia disease.
• We identified that elevated RTN3 will induce lipid droplets expansion.
• We found that the RTN3-heat shock protein family A (Hsp70) member 5 interaction activates sterol regulatory element-binding protein 1c and induces obesity and triglyceride accumulation.
What Are the Clinical Implications?
• The present finding of a positive correlation between plasma RTN3 levels and triglyceride accumulation may provide a novel biomarker for obesity and hypertriglyceridemia.
• Overexpression of RTN3 can induce obesity and hypertriglyceridemia, which may bear clinical potential for the treatment of obesity and hypertriglyceridemia.
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were enrolled from the Second Xiangya Hospital of Central South University. Fat tissue was collected from patients undergoing liposuction, and control fat tissue was collected from surgical operations on patients with congenital heart defects. All patients provided written informed consent. The RTN1-4 antibody was generated in the Yan laboratory. 20 HSPA5, SREBP cleavage-activating protein (SCAP), SREBP-1c, AMPK, phosphorylated AMPK, and GAPDH antibodies were purchased from Cell Signaling Technology. Borondipyrromethene (BODIPY) and Nile Red dye were purchased from Thermo Fisher. The control diet was purchased from Shanghai SLAC Laboratory Animal Co Ltd. The HFD was purchased from TROPHIC Animal Feed High-Tech Co, Ltd, China, and consisted of 60% fat, 20% protein, and 20% carbohydrate.
C elegans Strains and Transgenes
Nematode growth media was used to maintain C elegans with OP50 Escherichia coli at 20°C. 21 The WT strain was N2 (Bristol), and the mutant strain used in this study was daf-22 (ok693). 22 Germline transgene experiments were performed as described previously. 23 Transgene mixtures contained 10 ng/μL pPD95.79::ret-1p::ret-1 and 20 ng/μL pPD95.86::green fluorescent protein (myo-3p::green fluorescent protein) plasmid (which expresses green fluorescent protein in body-wall muscles) as a coinjection marker.
RNAi Screening
Young adult C elegans were fed HT115 (DE3) bacteria containing plasmids expressing dsRNAs targeting ret-1 on nematode growth media plates with 1 mmol/L isopropyl β-d-1-thiogalactopyranoside and 0.1 mg/mL ampicillin for 2 days.
Coimmunoprecipitation and Western Blot Analyses
For Western blotting, fat tissue and liver tissue were homogenized on ice in 1% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate extraction buffer containing complete protease inhibitors (Roche Bioscience, No. 04693159001) and 0.1 mmol/L Na 3 VO 4 for inhibiting phosphatase. The homogenates were rotated for 30 minutes at 4°C to ensure extraction of membrane proteins. After centrifugation at 15 000g for 120 minutes, supernatants were collected, and protein concentration was measured with the bicinchoninic acid protein assay reagent (Pierce). Equal amounts of protein lysates were resolved on 4% to 12% Bis-Tris NuPAGE gels, followed by standard Western blotting with the antibodies specified above. Chemiluminescent signals were scanned, and integrated density values were calculated with a chemiluminescent imaging system (Alpha Innotech).
For coimmunoprecipitation, 3T3L1 cells were first grown in DMEM for 24 hours in 60-mm plates to ≈80% confluence and then transfected with the indicated expression constructs. After being cultured for 48 hours, cells were lysed, and equal amounts of lysates (500 μg in 1 mL) were used for immunoprecipitation with Myc-or Flag-conjugated beads overnight. The extensively washed immunoprecipitates were resolved on a 4% to 12% NuPage Bis-Tris gel, followed by standard Western blotting with the antibodies specified above. Chemiluminescent signals were scanned, and integrated density values were calculated with a chemiluminescent imaging system (Alpha Innotech).
Immunofluorescent Confocal Microscopy
BODIPY staining and Nile Red vital staining in live animals were essentially the same as described previously. 24 For BODIPY staining, 500 μL of 5 μmol/L C1-BODIPY-C12 (Invitrogen) in M9 buffer was added onto a 60-mm nematode growth media plate. For Nile Red staining, 100 μL of 5 μg/mL Nile Red (Invitrogen) in M9 buffer was added onto a 60-mm nematode growth media plate. The plates were immediately dried in a laminar flow hood and were used to grow and stain nematodes. C elegans were fixed in 4% paraformaldehyde on slides. After washed by PBS, slides were checked by confocal microscopy.
Hematoxylin-Eosin Staining
Paraformaldehyde-fixed fat tissue was embedded in paraffin and sliced into 6-µm sections. The sections were stained with hematoxylin-eosin and examined by routine light microscopy (Olympus Corp, Tokyo, Japan). Briefly, sections were dried, followed by xylene dewaxing and rehydration with decreasing concentrations of alcohol. The slides were then stained with hematoxylin for 15 minutes and differentiated with hydrochloric acid alcohol for 30 seconds. After staining with 1% ammonia, sections were stained with 1% eosin for 2 minutes, followed by dehydration in alcohol and mounting.
Immunohistochemistry
Immunohistochemistry experiments were performed with a Histostain-Plus Kit (Maibio, Shanghai, China). Liver tissue from mice was sectioned in the sagittal plane at a thickness of 10 μm with a cryostat after 4% paraformaldehyde fixation and optimal cutting temperature compound embedding.
Statistical Analysis
Data were subjected to statistical analysis with Graph Pad Prism 5 (GraphPad Software) and were plotted by AI Illustrator (Adobe). Results represent the mean±SEM of at least 3 independent experiments as indicated in the figure legends. Twotailed Student t tests based on ANOVA were used for 2-group comparisons. For multiple comparisons, we conducted 1-way ANOVAs with the Dunnett correction to analyze differences among the control group and ≥1 independent treatment groups. Differences were considered statistically significant at P<0.05, with significance indicated in figures.
RESULTS

RTN3 Transgenic Mice Exhibit a Phenotype Related to Obesity and Hypertriglyceridemia
Tg-RTN3 mice were previously generated to investigate the role of RTN3 in the regulation of β-secretase 1 activity and in the formation of dystrophic neurites. 16, 18, 24 However, it was also noted that Tg-RTN3 mice exhibited Figure 1A ). This higher body weight was prominent at 4 months of age with standard chow, with the average body weight of Tg-RTN3 mice being ≈45.03% higher compared with that of WT control littermates ( Figure 1B) . It was noticeable that the epididymis adipose tissues accumulated in Tg-RTN3 mice were ≈284% greater than in WT littermates ( Figure 1C ). Although the RTN3 transgene was targeted by prion promoter for neuronal expression, 11 we showed that RTN3 was also expressed in fat tissue; the expression of the RTN3 transgene was visibly higher than that of WT ( Figure 1D and 1E and Figure  I in the online-only Data Supplement). Plasma triglyceride levels in Tg-RTN3 mice were obviously increased compared with WT control littermates after 16 weeks of standard chow. The level of plasma triglycerides in Tg-RTN3 mice was increased to ≈188% compared with that in WT controls ( Figure 1F ). Thus, increased expression of RTN3 resulted in elevated levels of triglycerides in the plasma and fat tissue.
To further determine whether the accumulation of triglycerides alters LD size, we conducted hematoxylineosin staining to analyze the size of fat cells in Tg-RTN3 and WT control mice. We found that the fat cells in Tg-RTN3 mice were visibly and statistically larger than those in WT control mice ( Figure 1G and 1H) . We also found that the triglyceride levels of adipose tissue in Tg-RTN3 mice were higher than in WT controls ( Figure 1I ). These observations in Tg-RTN3 mice suggest that increased overexpression of RTN3 is sufficient to cause adipose tissue expansion by increasing the size of LDs in adipocytes and elevating triglyceride levels in the plasma.
Link Between High RTN3 Expression and Obesity/Hypertriglyceridemia in Humans
In obese patients (body mass index >28 kg/m 2 ), the LDs are also frequently larger than in nonobese individuals (Figure 2A and 2B) . We therefore further explored the relationship between the expression of RTN3 and obesity. To test the hypothesis that RTN3 participates in LD expansion and triglyceride accumulation in humans, we collected adipose biopsy samples from obese individuals and control subjects with normal body weight (body mass index <23.7 kg/m 2 ). By Western blot analysis, we found that RTN3 levels were evidently higher in individuals with obesity (n=4) than in the control subjects with normal body weight (n=3; see examples in Figure 2C and 2D). 
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Furthermore, we collected peripheral blood samples (leukocytes) from individuals with obesity or hypertriglyceridemia (triglycerides >2.83 mmol/L). A total of 149 obese patients, 343 hypertriglyceridemic patients, and 84 healthy control subjects (18.5 kg/m 2 <body mass index<22.9 kg/m 2 , triglycerides <1.7 mmol/L) were enrolled in this study (Table) . The mean plasma triglyceride values of these 3 groups were 11.26±4.90, 7.82±5.17, and 1.05±0.80 mmol/L, respectively. There were 71 hypertriglyceridemic patients and 19 obese patients with a history of coronary heart disease or atherosclerosis (Table) . Western blot analysis of protein lysates from each individual's leukocytes was conducted. We found that 32.65% (112 of 343) of hypertriglyceridemic patients (top cluster) and 35.57% (53 of 149) of obese patients (top cluster) exhibited higher RTN3 levels compared with healthy control subjects (n=86), which were arbitrarily set as 1 for most representative cases ( Figure 2E ). In addition, we collected some fat tissue from hypertriglyceridemic patients (n=12) and healthy control subjects (n=2). Western blot analyses showed that the RTN3 levels in 3 hypertriglyceridemic patients' samples were much higher than those in healthy control subjects ( Figure 2F and 2G) . These findings indicate that RTN3 levels are elevated in patients with obesity and hypertriglyceridemia. All of these human data were consistent with our findings in the Tg-RTN3 mouse model. 
RTN3 Deficiency Leads to Resistance Against Triglyceride Accumulation After HFD
Because overexpression of RTN3 in mice can expand the size of LDs and increase plasma triglyceride levels, we then explored whether RTN3 deficiency would decrease LD size and triglyceride accumulation in a mouse model. We generated RTN3 homozygous knockout (RTN3 KO) mice using clustered regularly interspaced short palindromic repeats technology ( Figure 3A ). Contrary to our initial expectation, there were no obvious differences between RTN3 KO mice and WT mice in any age group ( Figure II in the online-only Data Supplement), suggesting that RTN3 deficiency has no obvious effect on adipose tissue accumulation during normal growth.
We next assessed whether RTN3 deficiency would affect LD size or triglyceride levels under stressed conditions such as an HFD, which is one of the major approaches to induce triglyceride accumulation. In our experiment, mice were fed HFD daily beginning at 8 weeks of age for 21 weeks. After 21 weeks of continuous HFD, WT mice exhibited visibly larger body size compared with RTN3 KO mice ( Figure 3B ). The body weight of HFD-fed WT mice at the age of 22 weeks on average was 46.23±1.86 g compared with 35 .74±1.15 g in HFD-fed RTN3 KO mice ( Figure 3C ).
We also examined fat tissue directly after HFD and found that RTN3 KO mice displayed diminished adipose tissue depots, with a 39.3% reduction in white fat pad mass of the epididymis compared with WT controls ( Figure 3D ). The levels of plasma triglycerides in HFDfed WT mice were much higher than those in WT mice fed a normal diet ( Figure 1F and Figure 3E) . Remarkably, the levels of triglycerides in RTN3 KO mice after HFD were lower compared with those in HFD-fed WT mice ( Figure 3E ).
In addition, hematoxylin-eosin staining revealed smaller fat cells in RTN3 KO mice compared with WT control littermates after 21 weeks of HFD ( Figure 3F and 3G). The triglyceride levels in adipose tissue in HFDfed RTN3 KO mice also were lower than in HFD-fed WT controls ( Figure 3H ). These data collectively indicate that the deletion of RTN3 in mice decreases triglyceride accumulation in plasma, as well as LD accumulation in fat tissue.
RET-1 Is Required for LD Expansion and Triglyceride Accumulation in C elegans
C elegans is an ideal animal model in LD research. In C elegans, ret-1 is the only rtn gene, and it has high homology to mammalian RTN3. To understand the effect of RTN3 on LD size, we altered the expression of ret-1 
ORIGINAL RESEARCH ARTICLE
in C elegans and monitored LD size with BODIPY and triglyceride levels with Nile Red. To better analyze LD size in C elegans, we first generated C elegans overexpressing ret-1 by plasmid injection ( Figure III in the online-only Data Supplement). Large LD size (diameter >3 µm) or average LD size and triglyceride levels were significantly increased in this group ( Figure 4A through 4D) . A previous study demonstrated that excess triglycerides in expanded LDs would be accumulated in C elegans lacking daf-22, which is the terminal thiolase for peroxisomal fatty acid β oxidation. 21 In WT background, ret-1 is not required for LD formation but participates in triglyceride accumulation. We then conducted suppressed expression of ret-1 by small interfering RNA silencing in a daf-22 mutant background. The results indicated that knocking down ret-1 expression suppressed LD expansion and reduced triglyceride levels ( Figure 4A through 4D) . All of these results in C elegans suggest that ret-1 is required for LD expansion and triglyceride accumulation. They also indicate that RTN3 may be a mammalian RTN gene conserved for the control of LD expansion and triglyceride accumulation.
Increased RTN3 Can Bind HSPA5 and Activate SREBP-1c and AMPK
To explore the underlying mechanism of elevated RTN3 in regulating LD size and triglyceride accumulation, we explored RTN3-interacting proteins in Tg-RTN3 mouse fat tissue by coimmunoprecipitation and mass spectrometric analyses. HSPA5 was identified as an RTN3-interacting protein (data not shown). This protein-to-protein interaction was further validated by coimmunoprecipitation experiments in 3T3L1 cells ( Figure 5A and Figure  IV in the online-only Data Supplement). HSPA5, also known as BIP/GRP78, is an ER chaperone facilitating a wide range of protein folding processes. 25, 26 Relevant to our study, HSPA5 has been shown to participate in the formation of a complex containing SREBP and SCAP by stabilizing SRENBP-SCAP complex substance. 27, 28 HSPA5 has also been shown to regulate the activation of SREBP-1c, which is a key transcription factor in promoting triglyceride lipid synthesis. 25, 29 The discovery of an interaction between RTN3 and HSPA5 raised the question of whether elevated RTN3 can increase binding to HSPA5 and further sequester HSPA5 physiological function. To address this question, we altered RTN3 expression in the 3T3L1 cell line by small interfering RNA knockdown or RTN3 overexpression. Our results showed that the total levels of HSPA5 were unaffected by altered RTN3 levels ( Figure 5B and 5C). However, coimmunoprecipitated HSPA5 was significantly greater in the Tg-RTN3 model than in WT or the small interfering RNA-RTN3 model ( Figure 5B and 5C). This increased interaction appeared to increase the levels of SCAP and activated SREBP-1c in the Tg-RTN3 model ( Figure 5B and 5C ). Immunohistochemistry staining further confirmed that expression levels of SREBP-1c ORIGINAL RESEARCH ARTICLE in Tg-RTN3 mouse liver tissue were higher than those in WT mice ( Figure 5D and 5E). In livers from HFD-fed RTN3 KO mice, SREBP-1c expression levels were lower than in HFD-fed WT mice ( Figure 5F and 5G).
In addition, to determine whether increased RTN3 induces LD expansion via interactions with HSPA5 and further regulates SREBP-1c expression, we knocked down the homologous genes of HSPA5 (hsp-4) and SREBP-1c (sbp-1) in C elegans overexpressing ret-1. We showed that knocking down hsp4 may induce the LD expansion, but knocking down sbp-1 suppressed LD expansion ( Figure 5H and 5I) . These results suggest that increased 
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RTN3 activates SREBP-1c by competitively binding to HSPA5. In return, SREBP-1c can further regulate the levels of triglyceride synthesis by inducing the activation of AMPK. 30, 31 We found that the levels of AMPK in WT, Tg-RTN3, HFD-fed WT, and HFD-fed RTN3 KO groups were similar ( Figure 5J and 5K) . However, Tg-RTN3 mice exhibited higher levels of phosphorylated AMPK than WT mice ( Figure 5J and 5K) . Consistent with these findings, the levels of phosphorylated AMPK in HFD-fed WT mice were higher than those in HFD-fed RTN3 KO mice (Figure 5J and 5K) . Collectively, our data showed that with increased availability of RTN3, more HSPA5 will bind to RTN3 instead of the SREBP1-SCAP complex, consequently resulting in SREBP-1c activation, which plays a critical role in regulating triglyceride levels and LD size.
DISCUSSION
RTN3 is an ER membrane protein that appears to exert various biological functions such as modulating Aβ levels, apoptosis, and autophagic responses. 20, [32] [33] [34] [35] However, this protein is broadly expressed and has multiple spliced variants. 16 Whether this tubular ER-related protein is involved in lipid-related health and disease has never been revealed. In this study, we provide clinical and genetic evidence that the enhanced expression of RTN3 in fat tissue potentially leads to triglyceride accumulation and obesity. Our results may suggest a causative relationship between increased RTN3 and obesity or hypertriglyceridemia in patients.
The mechanism underlying how increased expression of RTN3 leads to obesity and triglyceride accumulation merits further exploration. In this study, we identified HSPA5 as a novel RTN3-interacting protein.
The activity of HSPA5 is crucial in regulating triglyceride accumulation and LD expansion. Lipid synthesis in mammalian cells is controlled by SREBPs, which are ER membrane-bound proteins. SREBP transcriptional activity is regulated through proteolytic cleavage at a leucine residue by S1P to release SREBP1c. 26, 28, 36 When SREBP forms a complex with SCAP, proteolytic cleavage activity is suppressed. HSPA5 is a protein that is important for maintaining the stability of the SREBP-SCAP complex substance to suppress S1P cleavage and lipid biosynthesis. 25, 27 In our study, we showed that the increased expression of RTN3 can facilitate interactions between RTN3 and HSPA5, thereby decreasing the activity of HSPA5 in stabilizing the SREBP-SCAP complex. Subsequently, the levels of free SCAP increased and eventually activated S1P to cleave SREBPS to form SREBP-1c (Figure 6) . Consistent with these results, we also found that competitive binding and activation of SREBP-1c induced LD expansion in C elegans. Moreover, we confirmed that phosphorylated AMPK, which is the downstream pathway of triglyceride accumulation, was also significantly increased in fat tissue of Tg-RTN3 mice and was higher in HFD-fed WT mice than in HFD-fed RTN3-null mice.
The theory that LDs emerge from the tubular ER is supported by results from various models for LD biogenesis. 37 Our findings are consistent with a previous report in which C elegans was used as the model organism to identify genes that are important for the control of LD size. 38 In this unbiased screening assay, tubular ERrelated proteins such as REEP2, REEP5, and atlastin were found to regulate LD size in the C elegans model. 21, 22 Here, we demonstrate that RTN3 plays an important role in the regulation of LD size because RTN3 deficiency is sufficient to mediate changes in LD size.
Many enzymes involved in neutral lipid synthesis are localized in the ER, suggesting a role for tubular ER proteins in the generation and expansion of LDs. 39 For example, neutral lipid-synthesizing enzymes such as DGAT1 and phospholipid-synthesizing enzymes such as choline phosphotransferase are localized in the ER. 40 Fat storage-inducing transmembrane proteins are part of the evolutionarily conserved FIT protein family, which resides in the ER. Overexpression of either FIT1 or FIT2 in mammalian cells results in the accumulation of LDs in skeletal muscle or murine liver in culture or in vivo. 41 It is likely that the physical link between tubular ER and LDs plays a critical role in the regulation of LD size.
We found that increased expression of RTN3 not only will expand LD size but also will cause accumulation of triglycerides. We revealed that plasma RTN3 was increased in hypertriglyceridemic patients in addition to individuals with obesity. The accumulation of triglycerides and the expansion of LD sizes were both observed in Tg-RTN3 mice and ret-1-overexpressing C elegans. This study provides evidence that RTN3 not only regulates triglyceride accumulation in plasma and fat tissue but also participates in LD expansion.
Among the RTN family, the C-terminal domains of the 4 members have an RTN homology domain with similar functions. 10 It has been demonstrated that RTNs can form a homodimer or a heterodimer and activate different downstream signaling pathways. Overexpression of RTN3 or RTN4 has been shown to induce cell apoptosis in cultured cells. 33, 35 However, we did not find any association between obesity or triglyceride elevation and other RTN members, indicating a distinctive role of RTN3 in dyslipidemia and obesity among the RTN family.
CONCLUSIONS
Our study suggests that Tg-RTN3 mice might be an ideal model for research on obesity and hypertriglyceridemia because the model recapitulates the features of obesity. Increased RTN3 expression is a potential risk factor for excessive triglyceride storage in fat
